Three-Dimensional OctreoScan111 Spect of Abdominal Manifestation of Neuroendocrine Tumours

References

• Brazeau P, Vale W, Burgus R, et al. Hypothalamic immunoreactive pituitary growth hormone. Science 1973; 179: 77–9
   PubMed Web of Science ®Google Scholar
• Reichlin S. Somatostatin. N Engl J Med 1983; 309: 1495–501
   PubMed Web of Science ®Google Scholar
• Reubi J C, Häcki W H, Lamberts S WJ. Hormone-producing gastrointestinal tumors contain a high density of somatostatin receptors. J Clin Endocrinol Metab 1987; 65: 1127–34
   PubMed Web of Science ®Google Scholar
• Reubi J-C, Kvols L, Krenning E, Lamberts S WJ. Distribution of somatostatin receptors in normal and tumor tissue. Metabolism 1990; 39(Suppl 2)78–81
   PubMedGoogle Scholar
• Reubi J-C, Kvols L K, Waser B, et al. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. Cancer Res 1990; 50: 5969–77
   PubMed Web of Science ®Google Scholar
• Kvols L K, Moertel C G, O'Connell M J, et al. Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. N Engl J Med 1986; 315: 663–6
   PubMed Web of Science ®Google Scholar
• Eriksson B, Öberg K, Andersson T, Lundqvist G, Wide L, Wilander E. Treatment of malignant endocrine pancreatic tumors with a new long-acting somatostatin analogue, SMS 201–995. Scand J Gastroenterol 1988; 23: 508–12
   PubMed Web of Science ®Google Scholar
• Wynick D, Anderson J V, Williams S J, et al. Resistance of metastatic pancreatic endocrine tumors after long-term treatment with the somatostatin analogue octreotide (SMS 201–995). Clin Endocrinol 1989; 30: 385–8
   PubMedGoogle Scholar
• Tiensuu Janson E, Ahlstrom H, Andersson T, Oberg K. Octreotide and alpha-interferon, a new combination for the treatment of malignant carcinoid tumours. Eur J Cancer 1992; 28: 1647–50
   Google Scholar
• Lamberts S WJ, Krenning E, Reubi J-C. The role of somatostatin and its analogs in the diagnosis and treatment of tumours. Endocr Rev 1991; 12: 450–82
   PubMed Web of Science ®Google Scholar
• Krenning E P, Bakker W H, Breeman W AP, et al. Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin. Lancet 1989; 1: 242–4
   PubMed Web of Science ®Google Scholar
• Lamberts S WJ, Bakker W H, Reubi J-C, Krenning E P. So-matostatin-receptor imaging in the localization of endocrine tumors. N Engl J Med 1990; 323: 1246–9
   PubMed Web of Science ®Google Scholar
• Bakker W H, Albert R, Bruns C, et al. (111In-DTPA-D-Phe1)-Octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiola-belling and in vitro validation. Life Sci 1991; 49: 1583–91
   PubMed Web of Science ®Google Scholar
• Krenning E P, Bakker W H, Kooij P PM, et al. Somatostatin receptor scintigraphy with 111In-DTPA-D-Phe-octreotide in man: metabolism, dosimetry and comparison with 123I-Tyr3-oc-treotide. J Nucl Med 1992; 33: 652–8
   PubMed Web of Science ®Google Scholar
• Bakker W H, Krenning E P, Breeman W A, et al. Receptor scintigraphy with a radioiodinated somatostatin analogue: Radiolabeling, purification, biologic activity, and in vivo application in animals. J Nucl Med 1990; 31: 1501–9
   PubMed Web of Science ®Google Scholar
• Westlin J-E, Tiensu Janson E, Ahlström H, et al. Scintigraphy using a 111-Indium labelled somatostatin analogue for localization of neuro-endocrine tumours. Antibody Immunoconjugates and Radio-pharmaceuticals, (Accepted for publication)
   Google Scholar
• Wallis J W, Miller T R, Lerner C A, Kleerup E C. Three-dimensional display in nuclear medicine. IEEE Trans Biomed Eng 1989; 8: 297–303
   Google Scholar
• Wallis J W, Miller T R. Three-dimensional display in nuclear medicine and radiology. J Nucl Med 1991; 32: 534–46
   PubMedGoogle Scholar
• Ylä-Jääski J, Klein F, Kübler O. Fast direct display of volume data for medical diagnosis GVGIP. Graph Mod and Image Proc 1991; 53: 7–18
   Google Scholar
• Höhne H K, Bomans M, Pommert A, Reimer M, Tiede U, Wiebecke G. Rendering tomographic volume data: adequacy of methods for different modalities and organs. NATO ASI Series. 197–215, F 60:3D Imaging in Medicine
   Google Scholar